Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) "DEDAS"

Completed

Phase 1/2 Results N/A

References

Publications

  • Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W; DEDAS Investigators. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006 May;37(5):1227-31. Epub 2006 Mar 30. Pubmed ID:16574922

Related Links

Sources for Trial Information